ANNMARIE KENNY: Open Payments
NPI 1861645384 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 42 payments from 14 companies in 2025. Trend: 2023 $1,389 · 2024 $1,257 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $392 |
| Otsuka America Pharmaceutical, Inc. | 5 | $129 |
| Teva Pharmaceuticals USA, Inc. | 6 | $123 |
| Lundbeck LLC | 3 | $86 |
| Neurocrine BioSciences, Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Bausch Health US, LLC | 2 | $46 |
| Alkermes, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
Products named: CAPLYTA, REXULTI, UZEDY, INGREZZA, Auvelity, ARISTADA, VRAYLAR, Jornay PM.
Industry payments across NY — which companies pay providers there.
